Acknowledgements The authors wish to express their thanks for the excellent editorial support and suggestions provided by John Vahle, Bob Greenhill, John Foster, Chirukandath Gopinath, Rupert Kellner, Beth Mahler, Stuart Levin, Ken Schafer, Gordon Hard, Ian Pyrah, Charlotte Keenan, Maria-Luisa Phan Lung Whu, and Suzy Tirtodikromo
VK3019 is being positioned as a potential standalone weight-loss option or a complementary agent alongside existing GLP-1/GIP therapies
Consider what matters most to you
Maria Atkins and supported by experienced nurse practitioners and medical assistants, will review your health history, current medications, and wellness goals to determine the formulation that best supports your needs
When it comes to weight loss, most people focus on diets, workouts, and calorie tracking